🔗 Share this article TikTok Influencers Driving Parallel Market for Unlicensed Slimming Medication An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations. Experimental Drug Gaining Traction Online The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also obtaining promotional offers. Active Trade on Messaging Platforms Separately, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions. Understanding The Experimental Drug Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic. Healthcare Professionals Express Concerns However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering products of unknown origin. Some experts said the demand for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro. Legal Status and Implementation Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations. Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment. Service Reaction and Material Elimination Based on TikTok, the service has taken down problematic material and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures. Online Marketplace Activities Investigations also found groups with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence. Within minutes of entering one group, a vendor shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience. Item Information and Costs Within these groups, posts display dark colored packages with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”. Service Oversight and Safety Measures A spokesperson for Telegram said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Warnings “Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service. A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained. Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.” Producer Statement A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.